Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BIOLASE Inc    BIOL

Delayed Quote. Delayed  - 06/21 09:59:59 pm
1.005 USD   -3.37%
05/17 Toothwash Equipment Market 2017 - a-Dec, 3M Company, Biolase, Pla..
05/05 BIOLASE : Announces Management Change
05/03 BIOLASE : reports 1Q loss
SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
News SummaryMost relevantAll newsSector newsTweets 

BIOLASE Inc : BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/22/2013 | 02:44pm CEST
BIOLASE Expects to Continue to Generate Positive Cash Flow From Operations for 2013 Overall

IRVINE, CA -- (MARKETWIRE) -- 01/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that based on preliminary unaudited financial results, the Company expects to report that it generated positive cash flow from operations for Q4 2012.

"We are pleased with our preliminary unaudited financial results for Q4 2012. It is rewarding to see that our restructuring efforts over the past two years have enabled us to turn the Company around and that we are making significant progress toward achieving our financial goals," said Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOLASE INC
05/31 BIOLASE INC : BIOLASE to Present at the 7th Annual LD Micro Invitational
05/17 Toothwash Equipment Market 2017 - a-Dec, 3M Company, Biolase, Planmeca Oy, Da..
05/16 BIOLASE, INC : Submission of Matters to a Vote of Security Holders (form 8-K)
05/05 BIOLASE : Announces Management Change
05/04 BIOLASE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
05/03 BIOLASE : reports 1Q loss
05/03 BIOLASE, INC : Results of Operations and Financial Condition, Financial Statemen..
05/03 BIOLASE : Reports 2017 First Quarter Results
04/26 BIOLASE : reg; to Host 2017 First Quarter Financial Results Conference Call on M..
04/20 BIOLASE, INC : Material Modification to Rights of Security Holders, Amendments t..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
08:45aDJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
06/08 BIOLASE (BIOL) Presents At 7th Annual LD Micro Invitational Conference - Slid..
05/03 BIOLASE's (BIOL) CEO Harold Flynn on Q1 2017 Results - Earnings Call Transcri..
05/03 Biolase reports Q1 results
04/13 BIOLASE to raise $10.5M in a private placement
03/14 BIOLASE (BIOL) Presents At 29th Annual ROTH Conference
Advertisement
Financials ($)
Sales 2017 55,0 M
EBIT 2017 -12,2 M
Net income 2017 -12,3 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018 -
Capi. / Sales 2017 1,24x
Capi. / Sales 2018 -
Capitalization 68,3 M
More Financials
Chart BIOLASE INC
Duration : Period :
BIOLASE Inc Technical Analysis Chart | BIOL | US0909111082 | 4-Traders
Full-screen chart
Technical analysis trends BIOLASE INC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 2,25 $
Spread / Average Target 124%
Consensus details
Managers
NameTitle
Harold C. Flynn President, Chief Executive Officer & Director
Paul N. Clark Chairman
Richard R. Whipp Vice President-Operations
Dmitri Boutoussov Vice President-Research & Development
Frederic H. Moll Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOLASE INC-28.21%71
THERMO FISHER SCIENTIF..24.45%68 726
DANAHER11.10%59 472
BOSTON SCIENTIFIC CORP..29.03%38 357
ROYAL PHILIPS14.36%34 998
INTUITIVE SURGICAL50.32%34 644
More Results